Delivery Order SPE2DB25D3201-SPE2DB25FNTPG
- Not listed
- The Defense Logistics Agency awarded a $43,815.44 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Neulasta OnPro 6 mg/0.6 mL kits. The contract represents a firm fixed price, non-competitive set-aside award with an ultimate completion date of April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.32 to AmerisourceBergen Drug Corp for Neulasta Onpro 6 mg/0.6 ml kits, with an ultimate completion date of August 28, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of DLA pharmaceutical procurements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.32 to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits on September 12, 2025, with completion expected by September 15, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,530.76 to AmerisourceBergen Drug Corp for Neulasta Onpro 6 mg/0.6 ml kits on September 9, 2025, with completion scheduled for September 10, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive selection among eligible contractors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18.7K to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Neulasta OnPro 6 mg/0.6 mL kits. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Neulasta is a specialty pharmaceutical product used to support patient recovery following chemotherapy...
- This is a $2,465.76 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's global military treatment programs and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,729.49, is for the supply of Neulasta OnPro 6 mg/0.6 ml kits to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,831.39, is for the delivery of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication. This contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of...
- This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEHG7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,011.96 firm fixed-price delivery order is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a prescription medication, with an ultimate completion date of April 11, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,215,932 units of the pharmaceutical product NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML. The order, with a potential value of $8,897.37, has a completion date of January 3, 2024. The award was made on January 2, 2024, and no set-aside designations were used. Amerisourcebergen Drug Corp, through its Corporate Office division, is an...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNTPGDelivery Order
The Defense Logistics Agency awarded a $3,505.98 delivery order to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL kits, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader pharmaceutical supply agreement with the federal government. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal presence through multiple competitively awarded contracts covering a broad range of pharmaceutical products and medical commodities across various therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 6/2/25 |